AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 221 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $163,000 | -41.6% | 3,531 | -2.5% | 0.00% | -50.0% |
| Q3 2018 | $279,000 | +6.9% | 3,622 | +16.8% | 0.00% | 0.0% |
| Q2 2018 | $261,000 | +2.8% | 3,102 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $254,000 | +38.8% | 3,102 | -3.1% | 0.00% | +33.3% |
| Q4 2017 | $183,000 | -28.0% | 3,200 | -15.8% | 0.00% | -25.0% |
| Q3 2017 | $254,000 | +209.8% | 3,800 | +137.5% | 0.00% | +300.0% |
| Q2 2017 | $82,000 | -21.9% | 1,600 | -11.1% | 0.00% | -50.0% |
| Q1 2017 | $105,000 | – | 1,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |